Cargando…

Erratum to atractylodin may induce ferroptosis of human hepatocellular carcinoma cells

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477627/ https://www.ncbi.nlm.nih.gov/pubmed/37675338 http://dx.doi.org/10.21037/atm-2023-15

Ejemplares similares

Atractylodin may induce ferroptosis of human hepatocellular carcinoma cells
por: He, Yongfei, et al.
Publicado: (2021)

ERRATUM: A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Liu, Bin, et al.
Publicado: (2015)

Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis
por: Ye, Qingyan, et al.
Publicado: (2023)

Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum
por: Xie, Zucheng, et al.
Publicado: (2022)

Erratum for Juvenile Hepatocellular Carcinoma in a Healthy Liver
por: Onishi, Sachiyo, et al.
Publicado: (2022)

Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma: Erratum
por: Liu, Zhikui, et al.
Publicado: (2023)

Erratum: Management of Hepatocellular Carcinoma: Current Status and Future Directions
Publicado: (2015)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Erratum to the genetic association between type 2 diabetic and hepatocellular carcinomas
Publicado: (2022)

Erratum: “Targeting the Macrophage: Immune Cells May Be the Key to Phthalate-Induced Liver Toxicity”
por: Schmidt, Silke
Publicado: (2022)

Erratum to: Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2013)

Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
por: Choi, Sung Hoon, et al.
Publicado: (2017)

Erratum to: Hepatocellular carcinoma with extrahepatic blood supply from right renal artery
por: Sohail, Amir Humza, et al.
Publicado: (2021)

Erratum, Vol. 9, May 10 Release
Publicado: (2012)

Erratum, Vol. 9, May 31 Release
Publicado: (2012)

Erratum, Vol. 12, May 7 Release
Publicado: (2015)

Erratum, Vol. 12, May 21 Release
Publicado: (2015)

Erratum, Vol. 15, May 3 Release
Publicado: (2018)

Erratum, Vol. 15, May 10 Release
Publicado: (2018)

Erratum, Volume 16, May 23 Release
Publicado: (2019)

Erratum, Vol. 13, May 26 Release
Publicado: (2016)

Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
por: Buta, Corina, et al.
Publicado: (2016)

Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
Publicado: (2022)

Erratum to “Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot study”
por: Yu, Zusheng, et al.
Publicado: (2022)

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis: Erratum
Publicado: (2015)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results: Erratum
Publicado: (2017)

Erratum to “Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab”
Publicado: (2021)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

Hopea odorata Extract Inhibits Hepatocellular Carcinoma via Induction of Caspase-Dependent Apoptosis [Erratum]
Publicado: (2022)

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection: Erratum
Publicado: (2016)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma: Erratum
Publicado: (2015)

Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma: Erratum
Publicado: (2015)

Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: an updated meta-analysis: Erratum
Publicado: (2020)

Erratum: Ferroptosis-related Genes for Overall Survival Prediction in Patients with Colorectal Cancer can be Inhibited by Gallic acid
por: Hong, Zongchao, et al.
Publicado: (2021)

Erratum for Ferroptosis-related Genes for Overall Survival Prediction in Patients with Colorectal Cancer can be Inhibited by Gallic acid
por: Hong, Zongchao, et al.
Publicado: (2022)

Erratum to: Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2
por: Huang, Ming-de, et al.
Publicado: (2017)

Atractylodin Ameliorates Colitis via PPARα Agonism
por: Heo, Gwangbeom, et al.
Publicado: (2023)

The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma
por: Muhamad, Nadda, et al.
Publicado: (2020)

MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2: Erratum
por: Wang, Yuan, et al.
Publicado: (2022)

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System: Erratum
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sb8dqb8bt368700qqifjfiuknk